Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Identifying high‐risk multiple myeloma patients: A novel approach using a clonal gene signature

International Journal of Cancer(2024)10.1002/ijc.35057Source: DataRank Database

Identifying high‐risk multiple myeloma patients: A novel approach using a clonal gene signature is a research paper published in International Journal of Cancer (2024). On theSindex it has a DataRank of 0.224. It has been cited 3 times, with 3 citing works in its 1-hop citation network.

N/A

0.224DataRank · unranked

Scored on demand from live citation data

Deposits data Open Access3 citations · 3 citing works in its network

Download PDF

Cite:

Data availability

Repositories this paper deposited data in (declared in PubMed).

dbGaPphs000748
GEOGSE136400 GSE24080 GSE9782 GSE19784 GSE6477

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 0.90)OA: greenTopics (31)IDs (PubMed, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 93%Citation Network 7%

Base Score Contribution

0.208

From this paper's citation signal

Citation Network Contribution

0.0162

From 2 citing papers with measurable signal

Learn more about DataRank methodology →

Top 3 citers driving the network score

Ranked by each citer's contribution to N(p) — log1p(C_q) divided by its reference count — out of 3 citers.

Identification and validation of a histone modification-related gene signature to predict the prognosis of multiple myeloma
Frontiers in Genetics20251 citations58 referencesContributes 0.012
Multi-omics profiling and AI-driven clinically deployable risk models in MGUS and smoldering myeloma
Clinical and Experimental Medicine20252 citations154 referencesContributes 0.007
Copy Number Alterations Suggest a Functional Switch from Innate Immunity to DNA Repair and Drive Clinical Heterogeneity in Plasma Cell Dyscrasias
International Journal of Translational Medicine20260 citations86 referencesContributes 0.000

Authors (3)

Christiana Wang ORCID,Chao Cheng ORCID,Jianrong Li ORCID

Live enrichment

PubMed:38874435 OpenAlex:https://openalex.org/W4399673870

National Cancer Institute

Grant: 1R01CA269764

Cancer Prevention and Research Institute of Texas

Grant: RR180061

FWCI

0.90

Citation Percentile

0.7%

Citation Trend

2025

2026

greenLicense: http://onlinelibrary.wiley.com/termsAndConditions#vor

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11537842/pdf/nihms-1999613.pdf

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.35057

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11537842/

journalhttps://doi.org/10.1002/ijc.35057

Fields of Study

Multiple Myeloma Research and TreatmentsProtein Degradation and Inhibitors14-3-3 protein interactions

MeSH Terms

DexamethasoneFemaleHumansMaleMultiple MyelomaPrognosisBiomarkers, TumorGene Expression Regulation, NeoplasticGene Expression ProfilingDNA Copy Number VariationsTranscriptome

Keywords

Multiple myelomaOncologyRisk stratificationGene expression profilingInternal medicineGene signatureBiomarkerMedicineGeneBiomarker discoveryDiseaseGene expressionComputational biologyBioinformaticsBiologyProteomicsGenetics